Logo image of EXE.PA

EXEL INDUSTRIES SA-A SHS (EXE.PA) Stock Fundamental Analysis

EPA:EXE - FR0004527638 - Common Stock

37.8 EUR
-0.1 (-0.26%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

5

EXE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 106 industry peers in the Machinery industry. EXE has only an average score on both its financial health and profitability. EXE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EXE was profitable.
In the past year EXE had a positive cash flow from operations.
EXE had positive earnings in 4 of the past 5 years.
EXE had a positive operating cash flow in 4 of the past 5 years.
EXE.PA Yearly Net Income VS EBIT VS OCF VS FCFEXE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of EXE (3.51%) is comparable to the rest of the industry.
EXE has a Return On Equity (6.73%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 6.89%, EXE is in the better half of the industry, outperforming 61.32% of the companies in the same industry.
EXE had an Average Return On Invested Capital over the past 3 years of 6.68%. This is below the industry average of 9.04%.
The last Return On Invested Capital (6.89%) for EXE is above the 3 year average (6.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROIC 6.89%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
EXE.PA Yearly ROA, ROE, ROICEXE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

EXE has a Profit Margin (2.83%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of EXE has grown nicely.
EXE's Operating Margin of 5.13% is in line compared to the rest of the industry. EXE outperforms 44.34% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
The Gross Margin of EXE (47.00%) is better than 62.26% of its industry peers.
EXE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.13%
PM (TTM) 2.83%
GM 47%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
EXE.PA Yearly Profit, Operating, Gross MarginsEXE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

EXE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, EXE has about the same amount of shares outstanding.
The number of shares outstanding for EXE remains at a similar level compared to 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
EXE.PA Yearly Shares OutstandingEXE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
EXE.PA Yearly Total Debt VS Total AssetsEXE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.84 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXE's Altman-Z score of 2.84 is fine compared to the rest of the industry. EXE outperforms 65.09% of its industry peers.
EXE has a debt to FCF ratio of 9.26. This is a negative value and a sign of low solvency as EXE would need 9.26 years to pay back of all of its debts.
The Debt to FCF ratio of EXE (9.26) is worse than 64.15% of its industry peers.
EXE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
EXE has a Debt to Equity ratio of 0.16. This is in the better half of the industry: EXE outperforms 72.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Altman-Z 2.84
ROIC/WACC1.04
WACC6.63%
EXE.PA Yearly LT Debt VS Equity VS FCFEXE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.75 indicates that EXE should not have too much problems paying its short term obligations.
EXE's Current ratio of 1.75 is fine compared to the rest of the industry. EXE outperforms 60.38% of its industry peers.
EXE has a Quick Ratio of 1.75. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.82, EXE is doing worse than 65.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.82
EXE.PA Yearly Current Assets VS Current LiabilitesEXE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

EXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.98%.
EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 50.29% yearly.
The Revenue has been growing slightly by 0.46% in the past year.
EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.19% yearly.
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%

3.2 Future

EXE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.53% yearly.
Based on estimates for the next years, EXE will show a decrease in Revenue. The Revenue will decrease by -0.88% on average per year.
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue Next Year-8.38%
Revenue Next 2Y-3.11%
Revenue Next 3Y-0.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXE.PA Yearly Revenue VS EstimatesEXE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
EXE.PA Yearly EPS VS EstimatesEXE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.22 indicates a reasonable valuation of EXE.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 91.51% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, EXE is valued rather cheaply.
EXE is valuated correctly with a Price/Forward Earnings ratio of 12.64.
EXE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 66.04% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, EXE is valued rather cheaply.
Industry RankSector Rank
PE 8.22
Fwd PE 12.64
EXE.PA Price Earnings VS Forward Price EarningsEXE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EXE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EXE is cheaper than 86.79% of the companies in the same industry.
70.75% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.29
EV/EBITDA 4.45
EXE.PA Per share dataEXE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

EXE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%

6

5. Dividend

5.1 Amount

EXE has a Yearly Dividend Yield of 3.03%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.82, EXE pays a better dividend. On top of this EXE pays more dividend than 85.85% of the companies listed in the same industry.
EXE's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.03%

5.2 History

The dividend of EXE is nicely growing with an annual growth rate of 6.63%!
Dividend Growth(5Y)6.63%
Div Incr Years1
Div Non Decr Years1
EXE.PA Yearly Dividends per shareEXE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

34.22% of the earnings are spent on dividend by EXE. This is a low number and sustainable payout ratio.
DP34.22%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EXE.PA Yearly Income VS Free CF VS DividendEXE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M
EXE.PA Dividend Payout.EXE.PA Dividend Payout, showing the Payout Ratio.EXE.PA Dividend Payout.PayoutRetained Earnings

EXEL INDUSTRIES SA-A SHS

EPA:EXE (8/22/2025, 7:00:00 PM)

37.8

-0.1 (-0.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-24 2025-10-24
Inst Owners8.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap256.66M
Analysts48.89
Price Target41.48 (9.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.03%
Yearly Dividend1.57
Dividend Growth(5Y)6.63%
DP34.22%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.43%
PT rev (3m)-8.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-45.02%
EPS NY rev (3m)-45.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.13%
Revenue NY rev (3m)-5.13%
Valuation
Industry RankSector Rank
PE 8.22
Fwd PE 12.64
P/S 0.23
P/FCF 13.29
P/OCF 5.18
P/B 0.55
P/tB 0.69
EV/EBITDA 4.45
EPS(TTM)4.6
EY12.17%
EPS(NY)2.99
Fwd EY7.91%
FCF(TTM)2.84
FCFY7.52%
OCF(TTM)7.3
OCFY19.3%
SpS161.9
BVpS68.21
TBVpS54.64
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROCE 9.89%
ROIC 6.89%
ROICexc 7.56%
ROICexgc 9.18%
OM 5.13%
PM (TTM) 2.83%
GM 47%
FCFM 1.76%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
ROICexc(3y)7.49%
ROICexc(5y)7.69%
ROICexgc(3y)9.26%
ROICexgc(5y)9.78%
ROCE(3y)9.59%
ROCE(5y)9.66%
ROICexcg growth 3Y-11.14%
ROICexcg growth 5Y6.57%
ROICexc growth 3Y-8.43%
ROICexc growth 5Y6.79%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
F-Score7
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Debt/EBITDA 0.87
Cap/Depr 100.15%
Cap/Sales 2.75%
Interest Coverage 6.24
Cash Conversion 57.19%
Profit Quality 61.97%
Current Ratio 1.75
Quick Ratio 0.82
Altman-Z 2.84
F-Score7
WACC6.63%
ROIC/WACC1.04
Cap/Depr(3y)92.15%
Cap/Depr(5y)79.17%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%
Revenue Next Year-8.38%
Revenue Next 2Y-3.11%
Revenue Next 3Y-0.88%
Revenue Next 5YN/A
EBIT growth 1Y-15.46%
EBIT growth 3Y1.06%
EBIT growth 5Y11.48%
EBIT Next Year51.35%
EBIT Next 3Y18.78%
EBIT Next 5YN/A
FCF growth 1Y-69.03%
FCF growth 3Y-25.63%
FCF growth 5Y-8.04%
OCF growth 1Y-40.05%
OCF growth 3Y-7.67%
OCF growth 5Y4.57%